Sunday, April 10, 2011

Biotech Bawling

Like we want to hear it.

"Biotech industry says cuts will stifle; Federal budgets would slash aid; Mass. groups look to restore funding" by Donovan Slack and Carolyn Y. Johnson, Globe Staff / February 19, 2011

WASHINGTON — The Massachusetts biotech industry says an obscure provision in President Obama’s budget could deal it a “fatal blow’’ and cost the state untold numbers of jobs. A Bay State hospital says other proposed cuts would devastate its efforts to train pediatricians. And an array of research institutions fear what is coming next from a Republican budget proposal.

Now, in response to what some of them consider a misguided assault by Washington, some employers and industry groups from the Bay State are adding their voices to persuade Congress to curtail or eliminate the cuts. Much is at stake, they say, noting that the medical research, biotech, and pharmaceutical industries account for more than 46,000 jobs and $4.1 billion in salaries for Massachusetts residents.

Some Democratic lawmakers from the Bay State, including Senator John F. Kerry, have joined the fight....

--more--"  

Related

Genzyme’s income up for fourth quarter

Genzyme may lose some Mass. jobs

A same issue insult those two.  

Genzyme Corp. details next round of layoffs

Genzyme deal survived a culture clash

Termeer could gain $221.2m after sale

Lacking funds, biotech plant not apt to open

Life sciences firms return $6.6m in aid after new jobs fall through

Ex-chief of Biogen Idec paid $20.3m

Is it just me, or is there something obscene there?

5 life sciences firms loaned $3.75m

Life science firms win $23.9m in tax breaks

Also seeBiotech Giveaway Was Borrowed Money 

Yeah, the interest payments only cost you about $800,000 dollars, taxpayers -- for companies that rarely, if ever, make profit.   

At least the execs got paid good! 

I've heard enough whining, how about you?